Pharmacopeia Drug Discovery Company Profile

20:17 EST 18th February 2020 | BioPortfolio

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independently and with partners. Pharmacopeia's most advanced internal program is a dual-acting angiotensin and endothelin receptor antagonist (DARA) for hypertension and diabetic kidney disease for which Phase 1 clinical trials are underway. Other internal proprietary programs address primarily immunoregulation. Pharmacopeia's collaborative efforts have resulted in a portfolio that includes one partnered program currently in Phase 2 clinical trials targeting chronic obstructive pulmonary disease (COPD) and four partnered programs in Phase 1 clinical trials targeting rheumatoid arthritis, oncology, metabolic and inflammatory diseases. Four additional partnered compounds are in preclinical development. Pharmacopeia's current strategic partnerships are with Cephalon, GlaxoSmithKline, Organon and Wyeth.


3000 Eastpark Blvd.
New Jersey
United States of America


Phone: 609-452-3600
Fax: 609-452-3672

News Articles [1201 Associated News Articles listed on BioPortfolio]

AI in Drug Discovery Conference 2020

16 - 17 March 2020, London, UK. SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London. AI-empowered machine learning technologies hold the potential of...

Bayer and Exscientia Collaborate to Leverage the Potential of Artificial Intelligence in Cardiovascular and Oncology Drug Discovery

Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into a three-year, multi-target collaboration. The partners will work on early research p...

PhoreMost and C4X Discovery Announce Neurodegeneration Focused Drug Discovery Collaboration

PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and C4X Discovery Holdings plc, a pioneering drug discovery company, have ann...

Pharmacophore modeling and applications in drug discovery: challenges and recent advances

The most downloaded article from Drug Discovery Today in Q2 2010 was by Sheng-Yong Yang and deals with the application of pharmacophore modeling to drug discovery.

Scottish CRO Integrates Drug Discovery and Compound Management

At the BioCity Scotland incubator, BioAscent Discovery uses former Merck Sharp & Dohme facilities and works with the European Lead Factory’s platform to support a cross-functional environment f...

Takeda and Evotec initiate drug discovery collaboration

German drug discovery company Evotec has announced it has signed a multi-year drug discovery collaboration with Japanese pharma company Takeda....Read More... The post Takeda and Evotec initiate drug ...

Arctoris, Molecule join forces on drug discovery

The news comes as drug discovery rates are declining, the price of bringing a drug to market is increasing, and return on investment (ROI) on R&D is expected to hit 0% in the next few years.

Atomwise, Hansoh collaborate on small-molecule drug discovery

AI-focused drug discovery start-up Atomwise Inc. and Chinese biotech Jiangsu Hansoh Pharmaceutical Group Co. Ltd. (Hansoh) agreed to collaborate on the design and discovery of potential drug candidate...

Drugs and Medications [68 Associated Drugs and Medications listed on BioPortfolio]

Nitrous oxide [praxair mexico, s. de r.l. de c.v]


Acd blood-pack units (pl 146 plastic) [fenwal, inc.]

Oxygen [praxair mexico, s. de r.l. de c.v]


Cpda-1 [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) Blood-Pack™ Unit

Adsol red cell preservation solution system in plastic container (pl 146 plastic) [fenwal, inc.]

Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK™ Unit; TRANSFER-PACK™ Container with ADSOL™ Red Cell Preservation Solution

PubMed Articles [3043 Associated PubMed Articles listed on BioPortfolio]

Association between US Pharmacopeia (USP) monograph standards, generic entry and prescription drug costs.

Despite the importance of pharmacopeial standards, little is known regarding their effect on drug competition. Such information is of particular relevance given the rising costs of prescription drugs ...

Machine learning in drug discovery and development part 1 - a primer.

Artificial intelligence, in particular machine learning (ML), has emerged as a key promising pillar to overcome the high failure rate in drug development. Here, we present a primer on the ML algorithm...

Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk.

United States Pharmacopeia Chapter , which became effective on December 1, 2019, addresses handling of hazardous drugs in facilities that make compounded preparations. The Chapter includes minimum fac...

Fragment-based drug discovery using cryo-EMs.

Recent advances in cryo-electron microscopy (EM) structure determination have pushed the resolutions obtainable by the method into the range widely considered to be of utility for drug discovery. Here...

An overview of late-stage functionalization in today's drug discovery.

: Late-stage functionalization (LSF) can introduce important chemical groups in the very last steps of the synthesis. LSF has the potential to speed up the preparation of novel chemical entities and d...

Clinical Trials [3024 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

PCD New Gene Discovery

This is a new gene discovery program for individuals with PCD who do not have a specific genetic etiology identified. Research procedures involve a single blood draw from the affected indi...

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Using 'Guided-Discovery-Learning' to Optimize and Maximize Transfer of Surgical Simulation

The study is a randomized experimental study comparing two forms of learning; guided-discovery-learning and traditional instructional learning. Recruiting sixty-four participants, the inve...

Endometriosis Biomarker Discovery Study

This is a prospective, Single time point, discovery study intending to identify biomarkers that can differentiate endometriosis from other underlying reasons for pelvic pain. Patients unde...

Companies [2537 Associated Companies listed on BioPortfolio]

Pharmacopeia Incorporated

Pharmacopeia, Inc. is a leader in enabling technology and technology-based services that accelerate drug discovery and chemical development. Pharmacopeia's laboratory services segment - Pharmacopeia L...

Pharmacopeia Drug Discovery

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independen...


Pharmacopeia is a biopharmaceutical company developing small molecule therapeutics to meet the needs of large patient populations suffering from significant unmet medical needs. With multiple internal...

Molecular Simulations Incorporated

Molecular Simulations Inc., a subsidiary of Pharmacopeia, Inc., is a leading provider of molecular modeling, simulation, and informatics software to the world’s foremost pharmaceutical, biotechnolog...


ZBChem is A member of Zhejiang ZhongBao I/E Corp.,Ltd Since 1963.ZBChem is the biggest China Excipients supplier and also supply many kinds of Cosmetic raw materials, Intermediates and API’s Guaran...

More Information about "Pharmacopeia Drug Discovery" on BioPortfolio

We have published hundreds of Pharmacopeia Drug Discovery news stories on BioPortfolio along with dozens of Pharmacopeia Drug Discovery Clinical Trials and PubMed Articles about Pharmacopeia Drug Discovery for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pharmacopeia Drug Discovery Companies in our database. You can also find out about relevant Pharmacopeia Drug Discovery Drugs and Medications on this site too.

Quick Search

Relevant Topic

Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...

Corporate Database Quicklinks

Searches Linking to this Company Record